Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ADME of [14C]-Benznidazole in Healthy Males
NCT03739541Phase 1Completed
- Sponsor
- Exeltis
- Start
- Jul 2018
- Primary completion
- Sep 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of benznidazole in Chagas disease, sponsored by Exeltis. Primary endpoints: Maximum Plasma Concentration of Benznidazole and Mass balance of [14C]-Benznidazole. Started Jul 2018; status: completed.
02
Drugs
benznidazole
03
Conditions
Chagas disease
Beyond the preview
Go deeper on NCT03739541.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03739541.